Abstract
Neurofibromatosis type 1 (NF1) is a common inherited complex multi-system disorder associated with the growth of various benign and malignant tumors. About 40% of NF1 patients develop spinal tumors, of whom some have familial spinal neurofibromatosis (FSNF), a variant form of NF1 in which patients present with multiple bilateral spinal tumors but have few other clinical features of the disease. We have studied 22 spinal neurofibromas derived from 14 unrelated NF1 patients. Seven of these patients satisfied the diagnostic criteria of NF1 while the remaining seven had only few features of NF1. The latter group defined as FSNF harbored significantly higher number of missense or missense and splice-site germline mutations compared to the group with classical NF1. This is the first study to describe NF1 somatic mutations in spinal neurofibromas. Loss-of-heterozygosity (LOH) was identified in 8/22 of the spinal tumors, 75% of LOH observed was found to result from mitotic recombination, suggesting that this may represent a frequent mutational mechanisms in these benign tumors. No evidence for LOH of the TP53 gene was found in these tumors.
Similar content being viewed by others
References
Upadhyaya M, Huson SM, Davies M, Thomas N, Chuzhanova N, Giovannini S, Evans DG, Howard E, Kerr B, Griffiths S, Consoli C, Side L, Adams D, Pierpont M, Hachen R, Barnicoat A, Li H, Wallace P, Van Biervliet JP, Stevenson D, Viskochil D, Baralle D, Haan E, Riccardi V, Turnpenny P, Lazaro C, Messiaen L (2007) An absence of cutaneous neurofibroma associated with a 3-bp in-frame deletion in exon 17 of the NF1 gene (c.2970_2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation. Am J Hum Genet 80(1):140–151. doi:10.1086/510781
Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A (2007) Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44:81–88. doi:10.1136/jmg.2006.045906
Thakkar SD, Feigen U, Mautner VF (1999) Spinal tumours in neurofibromatosis type 1: an MRI study of frequency, multiplicity and variety. Neuroradiologie 41:625–629. doi:10.1007/s002340050814
Mautner VF, Asuagbor FA, Dombi E, Fünsterer C, Kluwe L, Wenzel R, Widemann BC, Friedman JM (2008) Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro-oncol 10:593–598. doi:10.1215/15228517-2008-011
Kluwe L, Tatagiba M, Fünsterer C, Mautner VF (2003) NF1 mutations and clinical spectrum in patients with spinal neurofibromas. J Med Genet 40(5):368–371. doi:10.1136/jmg.40.5.368
Pulst SM, Riccardi VM, Fain P, Korenberg JR (1991) Familial spinal neurofibromatosis: clinical and DNA linkage analysis. Neurology 41:1923–1925
Ars E, Kruyer H, Gaona A, Casquero P, Rosell J, Volpini V, Serra E, Lazaro C, Estivill X (1998) A clinical variant of neurofibromatosis type 1: familial spinal neurofibromatosis with a frameshift mutation in the NF1 gene. Am J Hum Genet 62:834–841. doi:10.1086/301803
Poyhonen M, Leisti EL, Kytölä S, Leisti J (1997) Hereditary spinal neurofibromatosis: a rare form of NF1? J Med Genet 34:184–187. doi:10.1136/jmg.34.3.184
Kaufmann D, Müller R, Bartelt B, Wolf M, Kunzi-Rapp K, Hanemann CO, Fahsold R, Hein C, Vogel W, Assum G (2001) Spinal neurofibromatosis without café-au-lait macules in two families with null mutations of the NF1 gene. Am J Hum Genet 69:1395–1400. doi:10.1086/324648
Wimmer K, Mühlbauer M, Eckart M, Callens T, Rehder H, Birkner T, Leroy JG, Fonatsch C, Messiaen L (2002) A patient severely affected by spinal neurofibromas carries a recurrent splice site mutation in the NF1 gene. Eur J Hum Genet 10:334–338. doi:10.1038/sj.ejhg.5200807
Messiae L, Riccardi V, Peltonen J, Maertens O, Callens T, Karvonen SL, Leisti E-L, Koivunen J, Vandenbroucke I, Stephens K, Pöyhönen M (2003) Independent NF1 mutations in two large families with spinal neurofibromatosis. J Med Genet 40:122–126. doi:10.1136/jmg.40.2.122
Messiaen L, Callens T, Williams JB Babovic-Vuksanovic, Huson S, Legius E, Mac Gardner R, Pascual-Castroviejo I, Plotkin S, Scaefer GB, Wilson M, Korf B (2007) Genotype-phenotype correlations in spinal NF. [Abstract 985] Presented at the annual meeting of The American Society of Human Genetics, October 25, 2007, San Diego, California. Available from: http://www.ashg.org/genetics/ashg07s/index.shtml
Upadhyaya M, Kluwe L, Spurlock G, Mantripragada K, Monem B, Majounie E, Ruggieri M, Chuzhanova N, Evan DG, Ferner R, Thomas N, Guha A, Mautner V (2008) The germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumours (MPNST). Hum Mutat 29:74–82. doi:10.1002/humu.20601
Upadhyaya M, Spurlock G, Monem B, Thomas N, Friedrich RE, Kluwe L, Mautner V (2008) Germline and somatic NF1 gene mutations in plexiform neurofibromas. Hum Mutat 29(8):E103−E111. Online publication.
Upadhyaya M, Han S, Consoli C, Majounie E, Horan M, Thomas N, Potts C, Griffiths S, Ruggieri M, von Deimling A, Cooper DN (2004) Characterisation of somatic mutational spectrum of neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumours. Hum Mutat 23:134–146. doi:10.1002/humu.10305
Griffiths S, Thompson P, Frayling I, Upadhyaya M (2006) Molecular diagnosis of neurofibromatosis type 1: 2 years experience. Fam Cancer 6:21–34. doi:10.1007/s10689-006-9001-3
Futreal PA, Barrett JC, Wiseman RW (1991) An Alu polymorphism intragenic to the TP53 gene. Nucleic Acids Res 19:6977. doi:10.1093/nar/19.24.6977
Legius E, Herman D, Wu R, Hall BK, Marynen P, Cassiman J (1994) TP53 mutations are frequent in malignant NF1 tumours. Gene Chromosome Canc 10:250–255. doi:10.1002/gcc.2870100405
Abeysinghe SS, Chuzhanova N, Krawczak M, Ball EV, Cooper DN (2003) Translocation and gross deletion breakpoints in human inherited disease and cancer I: nucleotide composition and recombination-associated motifs. Hum Mutat 22:229–244. doi:10.1002/humu.10254
Ball EV, Stenson PD, Krawczak M, Cooper DN, Chuzhanova NA (2005) Micro-deletions and micro-insertions causing human genetic disease: common mechanisms of mutagenesis and the role of local DNA sequence complexity. Hum Mutat 26:205–213. doi:10.1002/humu.20212
Bacolla A, Jaworski A, Larson JE, Jakupciak JP, Chuzhanova N, Abeysinghe SS, O'Connell CD, Cooper DN, Wells RD (2004) Breakpoints of gross deletions coincide with non-B DNA conformations. Proc Natl Acad Sci USA 101:14162–14167. doi:10.1073/pnas.0405974101
Gusev VD, Nemytikova LA, Chuzhanova NA (1999) On the complexity measures of genetic sequences. Bioinformatics 15:994–999. doi:10.1093/bioinformatics/15.12.994
Chuzhanova NA, Anassis EJ, Ball E, Krawczak M, Cooper DN (2003) Meta-analysis of indels causing human genetic disease: mechanisms of mutagenesis and the role of local DNA sequence complexity. Hum Mutat 21:28–44. doi:10.1002/humu.10146
Maertens O, De Schepper S, Vandesompele J, Heyns I, Janssens S, Speleman F, Legius E, Messiaen L (2007) Molecular dissection of isolated disease features in neurofibromatosis type 1. Am J Hum Genet 81:243–251. doi:10.1086/519562
Kehrer-Sawatzki H, Kluwe L, Sandig C, Kohn M, Wimmer K, Krammer U, Peyrl A, Jenne DE, Hansmann I, Mautner VF (2004) High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene. Am J Hum Genet 75(3):410–423. doi:10.1086/423624
Kehrer-Sawatzki H, Kluwe L, Fünsterer C, Mautner VF (2005) Extensively high load of internal tumors determined by whole body MRI scanning in a patient with neurofibromatosis type 1 and a non-LCR-mediated 2-Mb deletion in 17q11.2. Hum Genet 116:466–475. doi:10.1007/s00439-005-1265-4
Dorschner MO, Sybert VP, Weaver M, Pletcher BA, Stephens K (2000) NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. Hum Mol Genet 9:35–46. doi:10.1093/hmg/9.1.35
Kehrer-Sawatzki H, Tinschert S, Jenne DE (2003) Heterogeneity of breakpoints in non-LCR-mediated large constitutional deletions of the 17q11.2 NF1 tumour suppressor region. J Med Genet 40:E116. doi:10.1136/jmg.40.10.e116
Colman SD, Williams CA, Wallace MR (1995) Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 11:90–92. doi:10.1038/ng0995-90
Eisenbarth I, Beyer K, Krone W, Assum G (2000) Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1. Am J Hum Genet 66:393–401. doi:10.1086/302747
Serra E, Ars E, Ravella A, Sanchez A, Puig S, Rosenbaum T, Estivill X, Lazaro C (2001) Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations. Hum Genet 108:416–429. doi:10.1007/s004390100514
Maertens O, Brems H, Vandesompele J, De Raedt T, Heyns I, Rosenbaum T, De Schepper S, De Paepe A, Mortier G, Janssens S, Speleman F, Legius E, Messiaen L (2006) Comprehensive NF1 screening on cultured Schwann cells from neurofibromas. Hum Mutat 27:1030–1040. doi:10.1002/humu.20389
Spurlock G, Griffiths S, Uff J, Upadhyaya M (2007) Somatic alterations of the NF1 gene in an NF1 individual with multiple benign tumours (internal and external) and malignant tumour types. Fam Cancer 6:463–471. doi:10.1007/s10689-007-9149-5
Serra E, Rosenbaum T, Nadal M, Winner U, Ars E, Estivill X, Lazaro C (2001) Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas. Nat Genet 28:294–296. doi:10.1038/90148
De Raedt T, Maertens O, Brems H, Heyns I, Sciot R, Majounie E, Upadhyaya M, Speleman F, Messiaen L, Vermeesch JR, Legius E (2006) Loss of heterozygosity in neurofibromas: comparison of NF1 microdeletion and non-microdeletion patients. Gene Chromosome Canc 45:893–904. doi:10.1002/gcc.20353
Zheng H, Chang L, Patel N, Yang J, Lowe L, Burns DK, Zhu Y (2008) Induction of abnormal proliferation by non-myelinating schwann cells triggers neurofibroma formation. Cancer Cell 13:117–128.
Birindelli S, Perrone F, Oggionni M, Lavarino C, Pasini B, Vergani B, Ranzani GN, Pierotti MA, Pilotti S (2001) Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumours. Lab Invest 81:833–844
Pascual-Castroviejo I, Pascual-Pascual SI, Velazquez-Fragua R, Botella P, Viaño J (2007) Familial spinal neurofibromatosis. Neuropediatrics 38(2):105–108. doi:10.1055/s-2007-985136
Raponi M, Upadhyaya M, Baralle D (2006) Functional splicing assay shows a pathogenic intronic mutation in neurofibromatosis type 1 (NF1) due to intronic sequence exonization. Hum Mutat 27:294–295. doi:10.1002/humu.9412
Acknowledgments
We thank Cancer Research UK for financial support. We are grateful to all the patients and their families who have contributed to this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Upadhyaya, M., Spurlock, G., Kluwe, L. et al. The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas. Neurogenetics 10, 251–263 (2009). https://doi.org/10.1007/s10048-009-0178-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10048-009-0178-0